Matches in Wikidata for { <http://www.wikidata.org/entity/Q66074900> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q66074900 description "assaig clínic" @default.
- Q66074900 description "clinical trial" @default.
- Q66074900 description "clinical trial" @default.
- Q66074900 description "clinical trial" @default.
- Q66074900 description "clinical trial" @default.
- Q66074900 description "ensaio clínico" @default.
- Q66074900 description "ensayo clínico" @default.
- Q66074900 description "ensayu clínicu" @default.
- Q66074900 description "essai clinique" @default.
- Q66074900 description "klinisch onderzoek" @default.
- Q66074900 description "клінічне випробування" @default.
- Q66074900 name "MIROCALS: Modifying Immune Response and OutComes in ALS" @default.
- Q66074900 name "MIROCALS: Modifying Immune Response and OutComes in ALS" @default.
- Q66074900 type Item @default.
- Q66074900 label "MIROCALS: Modifying Immune Response and OutComes in ALS" @default.
- Q66074900 label "MIROCALS: Modifying Immune Response and OutComes in ALS" @default.
- Q66074900 prefLabel "MIROCALS: Modifying Immune Response and OutComes in ALS" @default.
- Q66074900 prefLabel "MIROCALS: Modifying Immune Response and OutComes in ALS" @default.
- Q66074900 P1050 Q66074900-03E01595-615C-47A0-BE71-A81AE830D482 @default.
- Q66074900 P1050 Q66074900-1FFCD407-A2D0-485D-89F5-5F9CF32D9378 @default.
- Q66074900 P1050 Q66074900-69A69001-D7D8-4DF3-B603-72E8974018BC @default.
- Q66074900 P1132 Q66074900-472461E7-7634-4E59-87A7-61DD516174CA @default.
- Q66074900 P1476 Q66074900-CEC17360-5A6B-4FCE-BEDD-92317EF3919B @default.
- Q66074900 P17 Q66074900-C6B2B6A4-EBE9-4F7B-9184-B1C608760FE1 @default.
- Q66074900 P17 Q66074900-EADB1813-CED6-4651-BD85-F490B455DD68 @default.
- Q66074900 P1813 Q66074900-C754ECAC-2B81-4FFD-9A12-E3E6B7BD9979 @default.
- Q66074900 P2899 Q66074900-51EEB896-7AD4-4791-9B60-1AC4D2B40B0C @default.
- Q66074900 P3098 Q66074900-1A78F899-6581-4CA4-A17C-642D4D0C54B8 @default.
- Q66074900 P31 Q66074900-F4528DA6-ACAC-4FF0-B572-B8C41B16036A @default.
- Q66074900 P4135 Q66074900-26CE933D-CCF9-42EB-A5A0-7421D6CA9C11 @default.
- Q66074900 P580 Q66074900-10EA76EB-5DEA-440B-BA64-600CC3C02E25 @default.
- Q66074900 P582 Q66074900-D2239C3B-4B1E-468E-91C8-4C8310613F6F @default.
- Q66074900 P6099 Q66074900-7E03F900-D685-4E79-9C6D-CFA2A70DF323 @default.
- Q66074900 P8363 Q66074900-6BDB2CA9-1FDB-40F3-9A18-FEE23940EE02 @default.
- Q66074900 P1050 Q140067 @default.
- Q66074900 P1050 Q206901 @default.
- Q66074900 P1050 Q3221083 @default.
- Q66074900 P1132 "+216" @default.
- Q66074900 P1476 "Efficacy and Safety of Low-dose IL-2 (Ld-IL-2) as a Treg Enhancer for Controlling Neuro-inflammation in Newly Diagnosed Amyotrophic Lateral Sclerosis (ALS) Patients: A Randomized, Double-blind, Placebo- Controlled, Phase-II Proof of Concept/ Proof of Mechanism Clinical Trial" @default.
- Q66074900 P17 Q142 @default.
- Q66074900 P17 Q145 @default.
- Q66074900 P1813 "MIROCALS" @default.
- Q66074900 P2899 "+18" @default.
- Q66074900 P3098 "NCT03039673" @default.
- Q66074900 P31 Q30612 @default.
- Q66074900 P4135 "+75" @default.
- Q66074900 P580 "2017-06-19T00:00:00Z" @default.
- Q66074900 P582 "2021-06-01T00:00:00Z" @default.
- Q66074900 P6099 Q42824440 @default.
- Q66074900 P8363 Q78089383 @default.